Conference
69P The diabetes drug canagliflozin sensitizes non-small cell lung cancer (NSCLC) to radiotherapy and chemotherapy
Authors
Tsakiridis T; Villani L; Broadfield L; Marcinko K; Tsakiridis E; Ellis P; Muti P; Steinberg G
Volume
13
Publisher
Elsevier
Publication Date
April 1, 2018
DOI
10.1016/s1556-0864(18)30345-9
Conference proceedings
Journal of Thoracic Oncology
Issue
4
ISSN
1556-0864